Literature DB >> 6149605

Action of nicotine on the respiratory activity of the diaphragm and genioglossus muscles and the nerves that innervate them.

M A Haxhiu, E Van Lunteren, W B Van de Graaff, K P Strohl, E N Bruce, J Mitra, N S Cherniack.   

Abstract

Nicotine is known to alter respiration by stimulating peripheral chemoreceptors and receptors within the brain. In this study the sites of action and the effects of nicotine on hypoglossal nerve activity were compared to its effects on phrenic activity in paralyzed, vagotomized and chloralose-anesthetized cats. Since anesthesia is known to affect respiratory responses, we also compared the effects of intravenous nicotine given to conscious unsedated cats on genioglossus and diaphragm electrical activity. In eight conscious animals intravenous doses of nicotine ranging between 10 ng and 200 micrograms increased genioglossus activity significantly more than diaphragm activity. Studies in 26 anesthetized animals included injection of nicotine, intravenously, in the lateral ventricles, and application of nicotine to the ventrolateral surface of the medulla (the putative site of the central chemoreceptors) before and after section of the carotid sinus nerves. With all these interventions, changes in hypoglossal nerve activity were significantly greater than changes in phrenic nerve activity. The responses to nicotine could be blocked by application of hexamethonium to the ventrolateral medullary surface or by cooling the same area. The results indicate that: nicotine increases hypoglossal nerve activity by both its peripheral and central effects; nicotine has differential effects on different respiratory muscles and nerves; and the central action of nicotine may be mediated largely through receptors located near the ventral medullary surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149605     DOI: 10.1016/0034-5687(84)90090-2

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  9 in total

1.  Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo.

Authors:  Xia Liu; Sandeep Sood; Hattie Liu; Richard L Horner
Journal:  J Physiol       Date:  2005-04-07       Impact factor: 5.182

2.  Association Between Benzodiazepine Receptor Agonists and Snoring Among Women in the Nurses' Health Study.

Authors:  Brian M Lin; Frank B Hu; Gary C Curhan
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-02-01       Impact factor: 6.223

3.  Mechanisms of ventilatory periodicities.

Authors:  A I Pack; A Gottschalk
Journal:  Ann Biomed Eng       Date:  1993 Sep-Oct       Impact factor: 3.934

4.  Stimulation of the hypothalamic paraventricular nucleus modulates cardiorespiratory responses via oxytocinergic innervation of neurons in pre-Botzinger complex.

Authors:  S O Mack; M Wu; P Kc; M A Haxhiu
Journal:  J Appl Physiol (1985)       Date:  2006-07-20

5.  Higher prevalence of smoking in patients diagnosed as having obstructive sleep apnea.

Authors:  R Kashyap; L M Hock; T J Bowman
Journal:  Sleep Breath       Date:  2001-12       Impact factor: 2.816

6.  Mechanisms underlying regulation of respiratory pattern by nicotine in preBötzinger complex.

Authors:  X M Shao; J L Feldman
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

7.  Central administration of nicotine suppresses tracheobronchial cough in anesthetized cats.

Authors:  I Poliacek; M J Rose; T E Pitts; A Mortensen; L W Corrie; P W Davenport; D C Bolser
Journal:  J Appl Physiol (1985)       Date:  2014-12-04

Review 8.  Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature.

Authors:  Luigi Taranto-Montemurro; Ludovico Messineo; Andrew Wellman
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

Review 9.  Update on obstructive sleep apnea and its relation to COPD.

Authors:  Brian Mieczkowski; Michael E Ezzie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.